Delivery Order SPE2DR25D3012-SPE2DR26F4B6Y
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.50 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order was issued on November 5, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine vaccine procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,330.22 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (12 years and older), 0.5 milliliter syringes, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,087.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5 mL syringes, with an ultimate completion date of November 20, 2025. This non-set-aside competitive award was issued on October 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,890.88 by the Defense Logistics Agency (DLA) on October 27, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 milliliter syringes. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of November 18, 2025. The award carries no set-aside designation, reflecting the company's competitive capability to serve...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,083.04 delivery order on June 2, 2025, for SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ML syringes, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $2,718.60 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) on November 6, 2025, with completion scheduled for December 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4B6YDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,202.77 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5ml syringes, with an ultimate completion date of December 5, 2025. This is a firm fixed price, non-set-aside contract performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, serves as a prime contractor for the DLA Medical Supply Chain, fulfilling pharmaceutical and vaccine procurement needs across military and veteran healthcare systems. The company maintains an extensive portfolio of competitively awarded contracts involving delivery orders with firm fixed pricing for a comprehensive range of pharmaceutical products, vaccines, and medical supplies. This award reflects the company's ongoing role as a key supplier within the DLA's pharmaceutical vendor network, supporting the Defense Health Agency and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 11/13/25 |